SpyGlass Pharma, Inc. (SGP) Operating cash flow 2024–2025
SpyGlass Pharma, Inc. (SGP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$32.7MFY2025 · since FY2024: -$22.0M → -$32.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.7M | -48.5% |
| FY2024 | -$22.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice